Lebouvier, N. | IICIMED

Lebouvier, N.

Publications

P223

Pharmaceuticals. 2020, 13, 186.

Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.


doi:10.3390/ph13080186

P208

J. Enzym. Inhib. Med. Chem. 2020, 35, 398-403.

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.


doi: 10.1080/14756366.2019.1705292

P57

Bioorg. Med. Chem. Lett. 2007,17(13), 3686-3689.

Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety.


P50

Tetrahedron Lett. 2006, 47, 6479-6483.

Efficient microwave-assisted synthesis of 2-phenyl-1-(1H-indol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol derivatives with potential antifungal activity.

 


P40

Mycology 2004, 11 (supplement 1), 43.

Antifungal activity of new azolylindole derivatives against Candida and Aspergillus. Proceedings of the 10th Congress of the European Confederation of Medical


P39

J. Enz. Inh. Med. Chem. 2004, 19, 451-457.

Synthesis and antileishmanial activity of 3-imidazolylalkylindoles. Part I.


Autres publications scientifiques

Brevets

Thèse

T13.

Synthèse et évaluation pharmacologique de composés indoliques ou apparentés à activité antifongique et antileishmanienne.


Nantes, 14 octobre 2004.